Human Longevity Funding: $330M Raised, Investors & Rounds
Human Longevity has raised $330M in total funding. Backed by Emerging Technology Partners, Celgene, GE Ventures.
Human Longevity funding overview
Human Longevity has raised $330M in total disclosed funding. That places its disclosed total in the $250M–$1B range. The round record for Human Longevity runs through 2019; nothing later has been disclosed. Investors on record include Emerging Technology Partners, Celgene, GE Ventures, Illumina. 4 distinct backers are named across the disclosed rounds.
Human Longevity at a glance
Total raised
$330M
Latest round date
November 2019
Notable investors
Emerging Technology Partners, Celgene, GE Ventures, Illumina
Frequently asked about Human Longevity funding
How much has Human Longevity raised?
Human Longevity has raised $330M in total disclosed funding across the rounds on record.
Who has invested in Human Longevity?
Emerging Technology Partners, Celgene, GE Ventures, Illumina are named among the investors backing Human Longevity.
What was the latest Human Longevity funding round?
No round stage has been disclosed for Human Longevity.
Where is Human Longevity based?
No headquarters location is disclosed for Human Longevity.
When did Human Longevity last raise?
The last disclosed Human Longevity round closed in November 2019.
We update the Human Longevity record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.
